CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 112	$ 3,658
Less: Income from discontinued operations, net of tax	0	(3,855)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations	436	488
Changes in working capital accounts, excluding the effects of acquisitions	(81)	(641)
Changes in deferred income taxes and other	(44)	4
Net cash provided by (used in) operating activities from continuing operations	423	(346)
Net cash provided by operating activities from discontinued operations	0	52
Net cash provided by (used in) operating activities	423	(294)
Cash flows from investing activities:
Capital expenditures	(182)	(158)
Acquisitions of businesses, net of cash acquired	(4)	(118)
Proceeds from settlement of cross-currency interest rate swaps and other	(1)	52
Net cash used in investing activities from continuing operations	(187)	(224)
Net cash (used in) provided by investing activities from discontinued operations(1)	(3)	6,368	[1]
Net cash (used in) provided by investing activities	(190)	6,144
Cash flows from financing activities:
Borrowings under revolving credit facilities	0	280
Repayments under revolving credit facilities	0	(280)
Proceeds from issuance of senior notes and term loans	550	2,200
Repayment of notes and term loans (including redemption premium)	(562)	(6,984)
Payments on long-term debt	(17)	(103)
Payments of debt issuance and deferred financing costs	(8)	(37)
Payments on license obligations	(26)	(30)
Purchase of L&W common stock	(145)	(203)
Purchase of SciPlay’s Class A common stock	23	18
Net redemptions of common stock under stock-based compensation plans and other	(20)	(35)
Net cash used in financing activities from continuing operations	(251)	(5,210)
Net cash used in financing activities from discontinued operations	0	(3)
Net cash used in financing activities	(251)	(5,213)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2)	(12)
(Decrease) increase in cash, cash equivalents and restricted cash	(20)	625
Cash, cash equivalents and restricted cash, beginning of period	967	701
Cash, cash equivalents and restricted cash, end of period	947	1,326
Less: Cash, cash equivalents and restricted cash of discontinued operations	0	0
Cash, cash equivalents and restricted cash of continuing operations, end of period	947	1,326
Supplemental cash flow information:
Cash paid for interest	221	271
Income taxes paid	119	497
Distributed earnings from equity investments	2	4
Cash paid for contingent consideration included in operating activities	9	0
Supplemental non-cash transactions:
Non-cash interest expense	8	12
Fair value of securities received in sale of discontinued operations	$ 0	$ 46

[1] (1) The nine months ended September 30, 2022 include $6,409 million in gross cash proceeds from the sale of discontinued operations, net of cash, cash equivalents and restricted cash transferred.